June 30, 2020

Goldfinch Bio

Goldfinch Bio Secures $100 Million in Series B Financing

June 29, 2020

Blueprint Medicines

Blueprint Medicines Announces Publication in The Lancet Oncology Showing Durable Clinical Benefits of AYVAKIT™ (avapritinib) in NAVIGATOR Trial Patients with PDGFRA D842V Mutant GIST

June 25, 2020


GBT Awards $250,000 in ACCEL Grants to Advance Access to Care for People Living with Sickle Cell Disease

June 25, 2020


Nurix Therapeutics Announces Formation Of DeCART Therapeutics To Advance New CAR T Therapies Using Targeted Protein Modulation

June 24, 2020

Fulcrum Therapeutics

Fulcrum Therapeutics Announces Initiation of Multi-Center Phase 3 (LOSVID) Trial with Losmapimod for Hospitalized COVID-19 Patients

Load More

Sign up for weekly portfolio news.